Beschreibung
InhaltsangabePart 1: Fundamentals and Prerequisites: Epidemiology and Statistics.- Relevant Diseases and Therapeutic Options.- Oncologic Diseases.- Vascular Diseases Relevant for Screening.- Pathology.-Tumor Biology.- Vascular Pathology.- Diagnostic Algorithms for Whole-Body Exams.- Personnel and Structural Prerequisites for Screening Programs.- Technical Prerequisites.- MRI.- CT.- Ultrasound.- Mammography.- PET-CT.- Risks and Legal Aspects.- Ethical Aspects of Screening and Preventive Diagnosis.- Cost-Benefit Analysis of Screening and Preventive Diagnosis.- Part 2: Organ-Related Examinations. Screening in Unselected Populations: Cardiovascular Diseases.- MRI.- CT.- Ultrasound of the Carotid Arteries.- Oncological Diseases.- Breast Cancer.- Renal Cancer - Ultrasound.- Colorectal Cancer.- Congenital Pediatric Diseases.- Pre- and Postnatal Kidney Screening.- Ultrasound Screening of the Infant Hip.- Alzheimer Disease.- Osteoporosis.- Preventive Diagnosis for Risk Groups: Exogenous Exposition.- Asbestos.- Heavy Smokers.- Lung Cancer Screening.- Characterization of Lung Nodules Using Radiological Imaging.-The Healed Tumor Patient.- Screening for Endometrial Cancer in Asymptomatic Patients Receiving Tamoxifen Therapy.- Genetic Disposition.- Breast Cancer.- C-Cell Carcinoma.- Predisposing Diseases.- Chronic Hepatitis and Liver Cirrhosis.- Autoimmune Disease, AIDS and Transplanted Patients.- Subject Index.- List of Contributors.
Produktsicherheitsverordnung
Hersteller: Springer Verlag GmbH
[email protected]Tiergartenstr. 17
DE 69121 Heidelberg
Inhalt
Part 1: Fundamentals and Prerequisites: Epidemiology and Statistics .- Relevant Diseases and Therapeutic Options.- Oncologic Diseases.- Vascular Diseases Relevant for Screening.- Pathology.-Tumor Biology.- Vascular Pathology.- Diagnostic Algorithms for Whole-Body Exams.- Personnel and Structural Prerequisites for Screening Programs.- Technical Prerequisites.- MRI.- CT.- Ultrasound.- Mammography.- PET-CT.- Risks and Legal Aspects.- Ethical Aspects of Screening and Preventive Diagnosis.- Cost-Benefit Analysis of Screening and Preventive Diagnosis.- Part 2: Organ-Related Examinations. Screening in Unselected Populations: Cardiovascular Diseases.- MRI.- CT.- Ultrasound of the Carotid Arteries.- Oncological Diseases.- Breast Cancer.- Renal Cancer - Ultrasound.- Colorectal Cancer.- Congenital Pediatric Diseases.- Pre- and Postnatal Kidney Screening.- Ultrasound Screening of the Infant Hip.- Alzheimer Disease .- Osteoporosis.- Preventive Diagnosis for Risk Groups: Exogenous Exposition.- Asbestos.- Heavy Smokers.- Lung Cancer Screening.- Characterization of Lung Nodules Using Radiological Imaging.-The Healed Tumor Patient.- Screening for Endometrial Cancer in Asymptomatic Patients Receiving Tamoxifen Therapy.- Genetic Disposition.- Breast Cancer.- C-Cell Carcinoma.- Predisposing Diseases.- Chronic Hepatitis and Liver Cirrhosis.- Autoimmune Disease, AIDS and Transplanted Patients .- Subject Index.- List of Contributors.